Pfizer
PFE
Pfizer (PFE) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 28, 2026
- EPS actual
- $0.77
- EPS estimate
- $0.68
- EPS surprise
- +12.87%
- Revenue surprise
- +4.41%
- Revenue
- $15.0B
- Revenue estimate
- $14.4B
- Reported
- Aug 4, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | $0.68 | $0.77 | +12.87% | $15.0B | SEC |
| Q1 2026 | May 5, 2026 | $0.72 | $0.75 | +3.92% | $14.5B | SEC |
| Q4 2025 | Feb 3, 2026 | $0.57 | $0.66 | +16.42% | $17.6B | SEC |
| Q3 2025 | Nov 4, 2025 | $0.63 | $0.87 | +37.53% | $16.7B | SEC |
| Q2 2025 | Aug 5, 2025 | $0.58 | $0.78 | +34.39% | $14.7B | SEC |
| Q1 2025 | Apr 29, 2025 | $0.67 | $0.92 | +38.22% | $13.7B | SEC |
| Q4 2024 | Feb 4, 2025 | $0.47 | $0.63 | +33.59% | $17.8B | SEC |
| Q3 2024 | Oct 29, 2024 | $0.61 | $1.06 | +72.53% | $17.7B | SEC |
| Q2 2024 | Jul 30, 2024 | $0.46 | $0.60 | +31.03% | $13.3B | SEC |
| Q1 2024 | May 1, 2024 | $0.52 | $0.82 | +58.98% | $14.9B | SEC |
| Q4 2023 | Jan 30, 2024 | −$0.16 | $0.10 | +163.21% | $14.2B | SEC |
| Q3 2023 | Oct 31, 2023 | −$0.08 | −$0.17 | −113.03% | $13.2B | SEC |
| Q2 2023 | Aug 1, 2023 | $0.57 | $0.67 | +17.52% | $12.7B | SEC |
| Q1 2023 | May 2, 2023 | $0.98 | $1.23 | +24.97% | $18.3B | SEC |
| Q4 2022 | Jan 31, 2023 | $1.05 | $1.14 | +8.91% | $24.3B | SEC |
| Q3 2022 | Nov 1, 2022 | $1.39 | $1.78 | +28.30% | $22.6B | SEC |
| Q2 2022 | Jul 28, 2022 | $1.72 | $2.04 | +18.30% | $27.7B | SEC |
| Q1 2022 | May 3, 2022 | $1.49 | $1.62 | +8.48% | $25.7B | SEC |
| Q4 2021 | Feb 8, 2022 | $0.87 | $1.08 | +23.54% | $23.8B | SEC |
| Q3 2021 | Nov 2, 2021 | $1.08 | $1.34 | +24.43% | $24.1B | SEC |
Quarterly revenue
Frequently asked questions
When did Pfizer (PFE) last report earnings?
Pfizer last reported on Aug 4, 2026, covering fiscal Q2 2026.
Did PFE beat earnings estimates?
Yes. Pfizer reported EPS of $0.77 for Q2 2026 against a $0.68 estimate — a 12.87% beat.
How much revenue did PFE report last quarter?
Pfizer reported $15.0B in revenue for Q2 2026, against a consensus estimate of $14.4B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.